The FDA has given marketing authorization to Zyn nicotine pouches. That doesn't necessarily mean they're safe to use, especially for young people, and experts say there's little evidence that they help adults quit smoking.

The Food and Drug Administration Thursday authorized marketing of 20 nicotine pouches — the first time the products have been greenlit by the agency. Nicotine pouches are tobacco-free sachets filled with nicotine and flavorings that are held between the gums and lips similar to snus,

In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches. The pouches, which are placed between the lip and gum, are tobacco-free but contain nicotine. They come in different strengths and a variety of flavors such as citrus, coffee, peppermint and berry.

This marketing decision from the FDA covers 2 nicotine strengths, 3 mg and 6 mg, and 10 flavors of the small tobacco-free synthetic pouches.

The FDA authorized the marketing of 20 Zyn products on Thursday, marking the first allowance for the fast-growing nicotine pouches.

FDA authorizes Zyn nicotine pouches, citing public health benefits for adult smokers, despite concerns over flavored products' appeal to teens.

The U.S. Food and Drug Administration authorized the marketing of 20 Zyn products on Thursday, marking the first such move by the regulator for the fast-growing nicotine pouches segment in the country.

The U.S. Food and Drug Administration formally authorized Zyn nicotine pouches for sale after conducting an "extensive scientific review" about their safety.